Resistance to Oncogenic Transformation in Revertant R1 of Human ras-Transformed NIH 3T3 cells

LITERATURE CITED

• Barbacid, M.. 1987. ras genes. Annu. Rev. Biochem. 56:779–827.
   PubMed Web of Science ®Google Scholar
• Bassin, R. H., and M. Noda. 1987. Oncogene inhibition by cellular genes. Adv. Viral Oncol. 6:103–127.
   Google Scholar
• Bos, J. L., E. R. Fearon, S. R. Hamilton, M. V. de Vries, J. H. van Boom, A. J. van der Eb, and B. Vogelstein. 1987. Prevalence of ras gene mutations in human colorectal cancers. Nature (London) 327:293–297.
   PubMed Web of Science ®Google Scholar
• Buss, J. E., and B. M. Seffton. 1986. Direct identification of palmitic acid as the lipid attached to p21ras. Mol. Cell. Biol. 6:116–122.
   PubMed Web of Science ®Google Scholar
• Eliyahu, D., D. Michalovitz, and M. Oren. 1985. Overproduction of p53 antigen makes established cells highly tumorigenic. Nature (London) 316:158–160.
   PubMed Web of Science ®Google Scholar
• Ellis, R. W., D. DeFeo, T. Y. Shih, M. A. Gonda, H. A. Young, N. Tsuchida, D. R. Lowy, and E. M. Scolnick. 1981. The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (London) 292:506–510.
   PubMed Web of Science ®Google Scholar
• Favera, R. D., F. Wong-Staal, and R. C. Gallo. 1981. one gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature (London) 299:61–63.
   Google Scholar
• Fearon, E. R., S. R. Hamilton, and B. Vogelstein. 1987. Clonal analysis of human colorectal tumors. Science 238:193–197.
   PubMed Web of Science ®Google Scholar
• Forrester, K., C. Almoguera, K. Han, W. E. Grizzle, and M. Perucho. 1987. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature (London) 327:298–303.
   PubMed Web of Science ®Google Scholar
• Gluzman, Y., R. J. Frisque, and J. Sambrook. 1980. Origin-defective mutants of SV40. Cold Spring Harbor Symp. Quant. Biol. 44:293–300.
   PubMedGoogle Scholar
• Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467.
   PubMed Web of Science ®Google Scholar
• Gunning, P., P. Ponte, L. Kedes, R. J. Hickey, and A. I. Skoultchi. 1984. Expression of human cardiac actin in mouse L cells: a sarcomeric actin associates with a nonmuscle cytoskeleton. Cell 36:709–715.
   PubMedGoogle Scholar
• Inoue, H., M. Yutsudo, and A. Hakura. 1983. Rat mutant cells showing temperature sensitivity for transformation by wild-type Moloney murine sarcoma virus. Virology 125:242–245.
   PubMedGoogle Scholar
• Katz, E., and B. J. Carter. 1986. A mutant cell line derived from NIH/3T3 cells: two oncogenes required for in vitro transformation. J. Natl. Cancer Inst. 77:909–914.
   PubMedGoogle Scholar
• Kuzumaki, N., A. Oda, S. Yamagiwa, N. Taniguchi, H. Kobayashi, and T. Oikawa. 1986. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21. J. Natl. Cancer Inst. 77:1273–1279.
   PubMedGoogle Scholar
• Kuzumaki, N., H. Minakawa, T. Miyazaki, S. Haraguchi, T. Matsuo, and T. O. Yoshida. 1982. Individually distinct tumor-specific cell surface antigen identified by monoclonal antibody on a Rous sarcoma virus-induced mouse tumor. J. Natl. Cancer Inst. 69:527–530.
   PubMedGoogle Scholar
• Littlefield, W. J.. 1964. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science 145:709–710.
   PubMed Web of Science ®Google Scholar
• Noda, M., Z. Selinger, E. M. Scolnick, and R. H. Bassin. 1983. Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc. Natl. Acad. Sci. USA 80:5602–5606.
   PubMed Web of Science ®Google Scholar
• Norton, J. D., and R. J. Avery. 1984. Integration of proviral DNA in Kirsten murine sarcoma virus-infected mouse fibroblasts. J. Gen. Virol. 65:309–316.
   PubMedGoogle Scholar
• Norton, J. D., F. Cook, P. C. Roberts, J. P. Clewley, and R. J. Avery. 1984. Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion. J. Virol. 50:439–444.
   PubMedGoogle Scholar
• Oikawa, T., N. Kuzumaki, T. Yamada, I. Chiba, and S. Yamagiwa. 1987. Suppression of transformed phenotypes in intraspecific somatic cell hybrid clones between the c-myc activating mouse plasmacytoma line and normal cells. Int. J. Cancer 39:604–610.
   PubMedGoogle Scholar
• Oikawa, T., Y. Yuhki, N. Kondoh, K. Abe, N. Yuhki, Y. Ogiso, and N. Kuzumaki. 1988. c-myc expression and transformed phenotypes in hybrid clones between mouse plasmacytoma S194 cells and normal spleen cells or fibroblasts. Int. J. Cancer 42:435–440.
   PubMedGoogle Scholar
• Oshimura, M., T. M. Gilmer, and J. C. Barrett. 1985. Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes. Nature (London) 316:636–639.
   PubMedGoogle Scholar
• Rassoulzadegan, M., A. Cowie, A. Carr, N. Glaichenhaus, R. Kamen, and F. Cuzin. 1982. The roles of individual polyoma virus early proteins in oncogenic transformation. Nature (London) 300:713–718.
   PubMed Web of Science ®Google Scholar
• Sacks, T. L., E. J. Hershey, and J. R. Stephenson. 1979. Abelson murine leukemia virus-infected cell lines defective in transformation. Virology 97:231–240.
   PubMedGoogle Scholar
• Samid, D., D. M. Flessate, and R. M. Friedman. 1987. Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine. Mol. Cell. Biol. 7:2196–2200.
   PubMed Web of Science ®Google Scholar
• Shih, C., and R. A. Weinberg. 1982. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29:161–169.
   PubMed Web of Science ®Google Scholar
• Snyder, M. A., J. M. Bishop, J. P. McGrath, and A. D. Levinson. 1985. A mutation at the ATP-binding site of pp60v-src abolishes kinase activity, transformation, and tumorigenicity. Mol. Cell. Biol. 5:1772–1779.
   PubMedGoogle Scholar
• Southern, E. M.. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503–517.
   PubMed Web of Science ®Google Scholar
• Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327–341.
   PubMedGoogle Scholar
• Stenman, G., E. O. Delorme, C. C. Lau, and R. Sager. 1987. Transfection with plasmid pSV2gptEJ induces chromosome rearrangements in CHEF cells. Proc. Natl. Acad. Sci. USA 84:184–188.
   PubMed Web of Science ®Google Scholar
• Stephenson, J. R., R. K. Reynolds, and S. A. Aaronson. 1973. Characterization of morphologic revertants of murine and avian sarcoma virus-transformed cells. J. Virol. 11:218–222.
   PubMedGoogle Scholar
• Tsuchida, N., M. Shih, R. V. Gilden, and M. Hatanaka. 1974. Mutants of nonproducer cell lines transformed by murine sarcoma virus. III. Detection and characterization of RNA specific for helper and sarcoma viruses. J. Exp. Med. 140:218–224.
   PubMedGoogle Scholar
• Ulsh, L. S., and T. Y. Shih. 1984. Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol. Cell. Biol. 4:1647–1652.
   PubMedGoogle Scholar
• Van Beveren, C., F. Van Straaten, j. A. Galleshaw, and I. M. Verma. 1981. Nucleotide sequence of the genome of a murine sarcoma virus. Cell 27:97–108.
   PubMed Web of Science ®Google Scholar
• Yagihashi, A., N. Sato, T. Torigoe, M. Okubo, A. Konno, N. Takahashi, T. Yamashita, K. Fujinaga, N. Kuzumaki, and K. Kikuchi. 1988. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast. Cancer Res. 48:2798–2804.
   PubMedGoogle Scholar
• Zarbl, H., J. Latreille, and P. Jolicoeur. 1987. Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes. Cell 51:357–369.
   PubMedGoogle Scholar